Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. RPID
stocks logo

RPID

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
11.20M
+36.29%
-0.230
+4.55%
8.90M
+23.53%
-0.210
-19.23%
9.40M
+29.44%
-0.200
-25.93%
Estimates Revision
The market is revising Upward the revenue expectations for Rapid Micro Biosystems, Inc. (RPID) for FY2025, with the revenue forecasts being adjusted by 4.44% over the past three months. During the same period, the stock price has changed by 48.16%.
Revenue Estimates for FY2025
Revise Upward
up Image
+4.44%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+2.2%
In Past 3 Month
Stock Price
Go Up
up Image
+48.16%
In Past 3 Month
Wall Street analysts forecast RPID stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RPID is 8.00 USD with a low forecast of 8.00 USD and a high forecast of 8.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast RPID stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RPID is 8.00 USD with a low forecast of 8.00 USD and a high forecast of 8.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 4.030
sliders
Low
8.00
Averages
8.00
High
8.00
Current: 4.030
sliders
Low
8.00
Averages
8.00
High
8.00
Lake Street
NULL -> Buy
initiated
$8
2025-07-28
Reason
Lake Street
Price Target
$8
2025-07-28
initiated
NULL -> Buy
Reason
Lake Street initiated coverage of Rapid Micro Biosystems with a Buy rating and $8 price target. Rapid is "emerging as the category leader" in microbial quality control automation with its Growth Direct platform, says the analyst, who believes the market has yet to fully appreciate the already existing scale and growing adoption of Growth Direct. The firm sees further upside as recurring revenue continues to scale given "the stickiness of the platform," the analyst added.
Keybanc
Paul Knight
Buy
Initiates
$8
2025-02-12
Reason
Keybanc
Paul Knight
Price Target
$8
2025-02-12
Initiates
Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Rapid Micro Biosystems Inc (RPID.O) is -4.74, compared to its 5-year average forward P/E of -3.32. For a more detailed relative valuation and DCF analysis to assess Rapid Micro Biosystems Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-3.32
Current PE
-4.74
Overvalued PE
0.60
Undervalued PE
-7.24

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-2.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
3.80
Undervalued EV/EBITDA
-7.80

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
6.35
Current PS
0.00
Overvalued PS
14.42
Undervalued PS
-1.72
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

RPID News & Events

Events Timeline

(ET)
2025-11-07
06:14:17
Rapid Micro Biosystems increases FY25 revenue forecast to $33.0M, up from $32M
select
2025-11-07
06:13:02
Rapid Micro Biosystems announces Q3 earnings per share of 26 cents, exceeding consensus estimate of 25 cents.
select
2025-09-22 (ET)
2025-09-22
08:13:01
Trinity Capital invests $45 million in growth funding for Rapid Micro Biosystems.
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.5
11-08Yahoo Finance
Highlights from Rapid Micro Biosystems Inc (RPID) Q3 2025 Earnings Call: Record Revenue Achieved

  • Third Quarter Financial Performance: Rapid Micro Biosystems Inc reported Q3 revenue of $7.8 million, with consumables revenue up 40% and service revenue increasing by 12%, contributing to a 30% year-over-year rise in recurring revenue.

  • Record Multi-System Order: The company secured a significant multi-system order from a top biopharma customer, indicating strong commercial momentum, although they anticipate a temporary decrease in service revenue in Q4.

  • Collaboration and Margin Outlook: Progress with Millipore Sigma is expected to enhance margins starting in the second half of 2026, despite current product margins being slightly negative.

  • Future Expectations: The company expects onshoring to positively impact business in 2027 and beyond, while gross margins for Q4 are projected to be in the mid-single digits due to ongoing profitability challenges.

[object Object]
Preview
9.5
11-07NASDAQ.COM
RAPID MICRO BIOSYSTEMS, INC. Reports Q3 Loss Below Expectations

  • Third Quarter Loss: RAPID MICRO BIOSYSTEMS, INC. reported a loss of -$11.51 million for the third quarter, which was worse than analysts' expectations of -$0.25 per share.

  • Revenue Growth: The company's revenue increased by 3.2% to $7.84 million compared to $7.60 million in the same period last year.

  • Earnings Comparison: The earnings per share remained unchanged at -$0.26, consistent with the previous year.

  • Full Year Guidance: The company provided a full-year revenue guidance of $33.0 million.

[object Object]
Preview
1.0
10-31Newsfilter
Rapid Micro Biosystems to Attend the Stifel 2025 Healthcare Conference

  • Company Participation: Rapid Micro Biosystems will participate in the Stifel 2025 Healthcare Conference on November 11, 2025, with a 30-minute Q&A session available via live webcast.

  • Company Overview: Rapid Micro Biosystems specializes in automation solutions for the healthcare sector, enhancing the manufacturing and quality control processes for products like biologics and vaccines through their Growth Direct system.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Rapid Micro Biosystems Inc (RPID) stock price today?

The current price of RPID is 4.03 USD — it has increased 0.75 % in the last trading day.

arrow icon

What is Rapid Micro Biosystems Inc (RPID)'s business?

Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.

arrow icon

What is the price predicton of RPID Stock?

Wall Street analysts forecast RPID stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RPID is 8.00 USD with a low forecast of 8.00 USD and a high forecast of 8.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Rapid Micro Biosystems Inc (RPID)'s revenue for the last quarter?

Rapid Micro Biosystems Inc revenue for the last quarter amounts to 7.84M USD, increased 3.08 % YoY.

arrow icon

What is Rapid Micro Biosystems Inc (RPID)'s earnings per share (EPS) for the last quarter?

Rapid Micro Biosystems Inc. EPS for the last quarter amounts to -0.26 USD, decreased -0.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Rapid Micro Biosystems Inc (RPID)'s fundamentals?

The market is revising Upward the revenue expectations for Rapid Micro Biosystems, Inc. (RPID) for FY2025, with the revenue forecasts being adjusted by 4.44% over the past three months. During the same period, the stock price has changed by 48.16%.
arrow icon

How many employees does Rapid Micro Biosystems Inc (RPID). have?

Rapid Micro Biosystems Inc (RPID) has 163 emplpoyees as of December 05 2025.

arrow icon

What is Rapid Micro Biosystems Inc (RPID) market cap?

Today RPID has the market capitalization of 178.62M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free